Massachusetts Financial Services Co. MA Sells 100,825 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Massachusetts Financial Services Co. MA lessened its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 4.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 2,418,098 shares of the company’s stock after selling 100,825 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Option Care Health were worth $56,100,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the 4th quarter valued at approximately $26,000. UMB Bank n.a. boosted its position in Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares in the last quarter. Signaturefd LLC grew its stake in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after buying an additional 1,005 shares during the last quarter. Quarry LP increased its holdings in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares in the last quarter. Finally, Blue Trust Inc. lifted its stake in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock valued at $109,000 after acquiring an additional 681 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Performance

NASDAQ OPCH opened at $33.54 on Friday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a fifty day simple moving average of $32.97 and a 200 day simple moving average of $28.51. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $35.53. The company has a market cap of $5.51 billion, a P/E ratio of 28.18, a PEG ratio of 2.30 and a beta of 1.07.

Wall Street Analyst Weigh In

OPCH has been the topic of a number of research reports. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a research report on Thursday, March 6th. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $26.00 to $35.00 in a report on Thursday, January 23rd. Finally, Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research report on Thursday, February 27th. Two investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.